Newborn screening involves testing newborns for treatable genetic and metabolic disorders. It is a public health program that aims to identify affected infants early to prevent health problems. The document discusses the goals and components of newborn screening programs, including the diseases tested for, sample collection procedures, screening techniques, result interpretation, and confirmatory testing. It provides statistics on the increasing number of babies screened in Kuwait over recent years, from around 3,000 in 2005 to over 31,000 in 2014.
Apgar is a quick test performed on a baby at 1 and 5 minutes after birth. The 1-minute score determines how well the baby tolerated the birthing process. The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb. In rare cases, the test will be done 10 minutes after birth.
Screening for any disorder in individuals is a strategy used for identifying a disease before the onset of signs or symptoms, thus enabling earlier detection and management with the aim to reduce morbidity and mortality.
Apgar is a quick test performed on a baby at 1 and 5 minutes after birth. The 1-minute score determines how well the baby tolerated the birthing process. The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb. In rare cases, the test will be done 10 minutes after birth.
Screening for any disorder in individuals is a strategy used for identifying a disease before the onset of signs or symptoms, thus enabling earlier detection and management with the aim to reduce morbidity and mortality.
The medical history may include an underlying disorder that predisposes the child to a condition that results in altered mental status. A child with diabetes may have ketoacidosis or hypoglycemia.
This presentation is all about how to run a high risk follow up clinic for newborns discharged from a level II/III newborn care unit. It has been prepared mainly based on NNF protocol & AIIMS protocol.
This presentation is part of and education series to pediatric healthcare providers in Syria and it may be useful to all practitioners working in low resource settings.
The medical history may include an underlying disorder that predisposes the child to a condition that results in altered mental status. A child with diabetes may have ketoacidosis or hypoglycemia.
This presentation is all about how to run a high risk follow up clinic for newborns discharged from a level II/III newborn care unit. It has been prepared mainly based on NNF protocol & AIIMS protocol.
This presentation is part of and education series to pediatric healthcare providers in Syria and it may be useful to all practitioners working in low resource settings.
MSUD is metabolic genetic error . It happens due to lack of an enzyem that degrades specific amino acids
Homocystinuria is also a metbolic genetic error due to an enzyme defficiency it leads to an accumulation of homocystein and related chemical in the blood
Reliability, accuracy and cost effectiveness of prenatal screeningRustem Celami
Dr. Genc Kabili, Dr. Rustem Celami
A scientific paper in prenatal care
Prenatal screening, genetic abnormalities, reliability, accuracy, cost-effectiveness
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Kuwait newborn screening 3
1. By Dr. Amir Abdelazim
Bachelor in med. &surg. -Egypt
MS . clinical pathology –Egypt
Egyptian fellowship
Newborn screening laboratories
2. Newborn screening (NBS) is a population-
based, preventive public health program
carried out in many countries throughout
the world
Newborn screening
3. Newborn screening is a public
health system made up of many
different yet integral parts
Newborn screening
Diagnosis
Screening
Management
Evaluation
Education
4. The primary goal of newborn
screening is the early
identification of affected
infants in time to prevent
serious health problems.
Newborn screening
5. To help children to have the best start in life
through timely newborn screening, early diagnosis and
treatment.
The cost of missing one of these conditions is immense
, both in human suffering and in financial terms.
Untreated infants can develop mental retardation,
serious health problems, or even die,
sometimes without a diagnosis
Newborn screening
Why ?
6. A suffering Maple Syrup Urine Disease
Can you imagine having a twin MSUD babies?
Newborn screening
8. Newborn screening
Aminoacidopathies
ASA,CIT,PKU,MSUD,HCYS,TYR-1
Organic Acidemias
MMA,PPA,MCD,MCC,IVA,PKT
,GA1,HMG
Fatty Acid Oxidation Defects
MCAD,VLCAD,LCHAD,TFPD
Congenital hypothyroidism
Congenital Adrenal Hyperplasia
Galactosemia
Biotinidase Deficiency
Panel of
22
disorders
By Tandem
ms/ms
By DELFIA
system
4
18
9. Criteria of diseases selected (WHO 1960)
• The condition should be an important health problem.
• There should be an accepted treatment for patients with recognized disease.
• Facilities for diagnosis and treatment should be available.
• There should be a recognizable latent or early symptomatic state.
• There should be a suitable test or examination.
• The test or examination should be acceptable to the population.
• The natural history of the condition, including development from latent to
declared disease, should be adequately understood.
• There should be an agreed policy on whom to treat as patients.
• The cost of case finding (including diagnosis and treatment of patients
diagnosed) should be economically balanced in relation to possible expenditure
on medical care as a whole.
• Case-finding should be a continuing process and not a “once and for all”
project.
Newborn screening
10. Most of diseases included in the screening program
are autosomal recessive
Newborn screening
12. Criteria for technique selection :
Acceptable sample collection and transportation.
Rapid (turn around time).
Sensitive ( very low false negatives).
Specific ( very low of false positives).
Cheap ( cost-effective).
Newborn screening
13. Newborn screening
1963: Guthrie test: One test/One disease
Sample prep: two hours
Manual Sample analysis: 48 hours
High False positive and false negative results
1994:ESI-MS/MS test: One test/30 diseases
Sample prep: two hours
Automated Sample analysis: 2 minutes
Low false positive and false negative results
14. Please use the term “Newborn Screen.” The
term “Genetic test” is confusing.
Newborn screening
NBS has usually referred to biochemical testing for
inherited “metabolic” disorders, that are correctable
by dietary or drug intervention
15. The ideal sample should be collected
between (48-72hour) of age .
Newborn screening
16. Early discharge
Before 24 hrs. there are false positive TSH , 17OH
progesterone & MMA/PPA
Also false negative PKU & TYR1
Otherwise refusal of parents to come back to the hospital
Newborn screening
17. Newborn screening
If the baby discharge
before 24 hrs. of age
provide them with a
referral form to the
Newborn Screening
office to collect
another
Premature baby
<33 week,<1.8kg
Collect fist sample
48-72 hrs of age
Then collect 2nd
sample after 2 weeks
Then collect 3rd
sample after 4 weeks
33. Newborn screening
Samples screened
for 22 disorder
through Tandem
and DELFIA
technique
High
risk
low
risk
The results of the screening tests are reviewed by a
biochemistry consultant in Al-sabah laboratory to
determine if the infant has :
A lower risk of having a disease (“screen negative”) or
A higher risk of having a disease (“screen positive”).
35. Newborn screening
High
risk
The positive results repeated two times
before informed to newborn screening
offices
If confirmed as positive screen reports send
to NSOs to evaluate the baby clinically and
collect confirmatory samples
DELFIA
REPORT
TMS
REPORT
36. Screening is a semi-quantitative test affected by
several issues e.g.
quality of the blood spot,
time of sample collection,
quality of sample prep,
condition of instrument diet of baby,
birth weight,
gestational age,
& others….
Newborn screening
37. It is important to highlight that
Screening does not cover all metabolic diseases and
that diagnosis is presumptive
screening may yield false-negative or false-positive
results
It is very important to indicate that a firm
diagnosis can only be reached after confirmation
Confirmatory testing can be done by same
technology or different approach on blood spot,
urine, plasma…
Newborn screening
42. Total number of filter papers received for screening
in Kuwait each year from 2005 to 2014
Newborn screening
Year Total NO. of filter
papers
2005 3029
2006 2547
2007 2438
2008 4714
2009 15287
2010 17692
2011 25228
2012 29779
2013 29517
2014 31987
0
5000
10000
15000
20000
25000
30000
35000